NO COMMON CAUSE LINKING INFLAMMATORY BOWEL DISEASE AND COLORECTAL CANCER (pp 246, 262)January 24, 2001Research published in this week's issue of THE LANCET does not support the theory that there may be a single genetic cause for inflammatory bowel disease (IBD) and colorectal cancer. The causes of IBD and colorectal cancer (which occurs more often in people with IBD) are unknown. Some researchers have suggested that IBD and colorectal cancer might share a common cause and, therefore, relatives of patients with IBD could be at an increased risk of this malignant disease. Johan Askling and colleagues from the Karolinska Institute, Stockholm, Sweden, aimed to assess cancer rates among first-degree relatives (parents, siblings, and offspring) of patients with IBD to try to establish whether an association between the two diseases exists. The investigators identified around 114,000 first-degree relatives by registry linkage and followed them up for cancer occurrence. They compared incidence of cancer among the relatives with rates in the general population. 560 colorectal cancers were identified among relatives. First-degree relatives of patients with Crohn's disease or ulcerative colitis were neither at increased risk of cancer overall, nor at increased risk of colorectal cancer. Relatives of patients with both IBD and colorectal cancer had, however, an 80% increased risk of colorectal cancer. In an accompanying Commentary (p 246), Fergus Shanahan from Cork University Hospital, Ireland, comments: "Colitis and colorectal cancer are more likely to have a cause-and-effect relation, which implies that optimum anti-inflammatory therapy will provide effective cancer prevention". He adds: "Although colitis and cancer do not share a common genetic cause, environmental factors such as smoking and the enteric bacterial flora may contribute to the pathogenesis of both processes". Contact: Dr Johan Askling, Department of Medical Epidemiology, Karolinska Institute, BOX 281, S-171 77 Stockholm, Sweden; T) +46 8 728 6163; F) +46 8 314975; E) johan.askling@mep.ki.se Professor Fergus Shanahan, Department of Medicine, Cork University Hospital, Cork, Ireland; T) +353 21 492 2221; F) +353 21 434 5300; E) fshanahan@ucc.ie Lancet |
|||||||||||||||||||||
| Related Colorectal Cancer Current Events and Colorectal Cancer News Articles 'Cross-talk' mechanism contributes to colorectal cancer Researchers at the University of Wisconsin-Madison School of Medicine and Public Health have identified a molecular mechanism that allows two powerful signaling pathways to interact and begin a process leading to colorectal tumors. African-Americans with colorectal cancer have poorer outcomes, lower survival rates New research published in the November issue of the Journal of the American College of Surgeons shows that African-American patients with colorectal cancer are more likely to be diagnosed with advanced disease and are less likely to undergo surgical procedures compared with Caucasians, suggesting that improvements in screening and rates of operation may reduce differences in colorectal cancer outcomes for African-Americans. Colon cancer screening more effective earlier in day, UCLA study finds The effectiveness of a screening colonoscopy may depend on the time of day it is performed. According to a new UCLA study, early-morning colonoscopies yielded more polyps per patient than later screenings, and fewer polyps were found hour by hour as the day progressed. 1 disease, not 1 demographic The Asian continent has nearly four billion people living in 47 different countries, and each of these groups has their own unique set of health issues. But when they come to the United States, they're often lumped into one large demographic: "Asian/Pacific Islander." Study shows unsedated colonoscopy for colorectal cancer screening well accepted by patients Researchers from Taiwan report in a new study that unsedated colonoscopy for primary colorectal cancer screening is well accepted in a majority of patients. M. D. Anderson redefines screening guidelines for breast, cervical and colorectal cancers Drawing on years of experience in cancer research and patient care, The University of Texas M. D. Anderson Cancer Center released today the most comprehensive, risk-based screening guidelines publicly available to date for breast, cervical and colorectal cancers. The bowels of infection Current research suggests that latent cytomegalovirus (CMV) infection may exacerbate inflammatory bowel disease (IBD). The related report by Onyeagocha et al, "Latent cytomegalovirus infection exacerbates experimental colitis," appears in the November 2009 issue of The American Journal of Pathology. How to Lower Costs, Waiting Times for Colonoscopies Colorectal cancer is a leading cause of cancer-related deaths in the United States, leading to over 50,000 fatalities every year. Excess body weight causes over 124,000 new cancers a year in Europe At least 124,000 new cancers in 2008 in Europe may have been caused by excess body weight, according to estimates from a new modelling study. Adding cetuximab to chemotherapy reduces advanced lung cancer death risk by 13 percent Patients with advanced non-small cell lung cancer who are given cetuximab (Erbitux) in addition to chemotherapy are 13% less likely to die than those who receive chemotherapy alone, regardless of which chemotherapy drug cocktail is used, new research finds. They also experience slower disease progression and an increased chance of tumour shrinkage. More Colorectal Cancer Current Events and Colorectal Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||